468 related articles for article (PubMed ID: 15953374)
21. [Superficial acral fibromyxoma of finger: report of a case with review of literature].
Wang QF; Pu Y; Wu YY; Wang J
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):682-5. PubMed ID: 20078973
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous CD34+ spindle cell neoplasms: Histopathologic features distinguish spindle cell lipoma, solitary fibrous tumor, and dermatofibrosarcoma protuberans.
Wood L; Fountaine TJ; Rosamilia L; Helm KF; Clarke LE
Am J Dermatopathol; 2010 Dec; 32(8):764-8. PubMed ID: 20559119
[TBL] [Abstract][Full Text] [Related]
23. Dermatofibrosarcoma protuberans with unusual sarcomatous transformation: a series of 4 cases with molecular confirmation.
Swaby MG; Evans HL; Fletcher CD; Prieto VG; Patel KU; Lev DC; Lòpez-Terrada D; Lazar AJ; Wang WL
Am J Dermatopathol; 2011 Jun; 33(4):354-60. PubMed ID: 21478726
[TBL] [Abstract][Full Text] [Related]
24. Acquired reactive digital fibroma: a clinicopathologic report of 5 cases of a new entity.
Plaza JA; Suster S; Prieto VG; Sangueza M
J Am Acad Dermatol; 2013 Oct; 69(4):603-8. PubMed ID: 23849562
[TBL] [Abstract][Full Text] [Related]
25. [Dermatofibrosarcoma Darier and Ferrand. Immunohistochemistry study of 38 cases. Research on a specific marker].
Declerck D; Claye C; Rotteleur G; Lecomte-Houcke M
Ann Pathol; 1997 Oct; 17(5):324-8. PubMed ID: 9471146
[TBL] [Abstract][Full Text] [Related]
26. Cellular angiofibroma and related fibromatous lesions of the vulva: report of a series of cases with a morphological spectrum wider than previously described.
McCluggage WG; Ganesan R; Hirschowitz L; Rollason TP
Histopathology; 2004 Oct; 45(4):360-8. PubMed ID: 15469474
[TBL] [Abstract][Full Text] [Related]
27. Dermatofibrosarcoma protuberans presenting as a subcutaneous mass: a clinicopathological study of 15 cases with exclusive or near-exclusive subcutaneous involvement.
Bague S; Folpe AL
Am J Dermatopathol; 2008 Aug; 30(4):327-32. PubMed ID: 18645303
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
West KL; Cardona DM; Su Z; Puri PK
Am J Dermatopathol; 2014 May; 36(5):414-9. PubMed ID: 24162384
[TBL] [Abstract][Full Text] [Related]
29. Sclerosing Dermatofibrosarcoma Protuberans Shows Significant Overlap With Sclerotic Fibroma in Both Routine and Immunohistochemical Analysis: A Potential Diagnostic Pitfall.
Abdaljaleel MY; North JP
Am J Dermatopathol; 2017 Feb; 39(2):83-88. PubMed ID: 28134725
[TBL] [Abstract][Full Text] [Related]
30. Fibroblastic connective tissue nevus: a rare cutaneous lesion analyzed in a series of 25 cases.
de Feraudy S; Fletcher CD
Am J Surg Pathol; 2012 Oct; 36(10):1509-15. PubMed ID: 22892597
[TBL] [Abstract][Full Text] [Related]
31. CD34-positive myxoid dermatofibrohistiocytoma of the skin: an indolent post-traumatic tumor that can be mistaken for dermatofibrosarcoma protuberans.
Al-Quran SZ; Russo JJ; Bandarchi-Chamkhaleh B; Hassanein AM
J Cutan Pathol; 2009 Jan; 36(1):84-6. PubMed ID: 19125740
[No Abstract] [Full Text] [Related]
32. CD34+ pigmented fibrous proliferations: the morphologic overlap between pigmented dermatofibromas and Bednar tumors.
McAllister JC; Recht B; Hoffman TE; Sundram UN
Am J Dermatopathol; 2008 Oct; 30(5):484-7. PubMed ID: 18806495
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
Li N; McNiff J; Hui P; Manfioletti G; Tallini G
Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans.
Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M
Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669
[TBL] [Abstract][Full Text] [Related]
35. Histologic and immunohistochemical evidence for considering ovarian myxoma as a variant of the thecoma-fibroma group of ovarian stromal tumors.
Costa MJ; Morris R; DeRose PB; Cohen C
Arch Pathol Lab Med; 1993 Aug; 117(8):802-8. PubMed ID: 7688213
[TBL] [Abstract][Full Text] [Related]
36. Atrophic dermatofibrosarcoma protuberans: an uncommon and misleading variant.
Wu JK; Malik MM; Egan CA
Australas J Dermatol; 2004 Aug; 45(3):175-7. PubMed ID: 15250897
[TBL] [Abstract][Full Text] [Related]
37. Dermatofibrosarcoma protuberans and its fibrosarcomatous variant with areas of myoid differentiation: a report of three cases.
Morimitsu Y; Hisaoka M; Okamoto S; Hashimoto H; Ushijima M
Histopathology; 1998 Jun; 32(6):547-51. PubMed ID: 9675594
[TBL] [Abstract][Full Text] [Related]
38. Solitary sclerotic fibroma of the skin: morphological characterization of the 'plywood-like pattern'.
Nakashima K; Yamada N; Adachi K; Yoshida Y; Yamamoto O
J Cutan Pathol; 2008 Oct; 35 Suppl 1():74-9. PubMed ID: 18544068
[TBL] [Abstract][Full Text] [Related]
39. Cytologic features of primary, recurrent, and metastatic dermatofibrosarcoma protuberans.
Domanski HA; Gustafson P
Cancer; 2002 Dec; 96(6):351-61. PubMed ID: 12478683
[TBL] [Abstract][Full Text] [Related]
40. Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma.
Mori T; Misago N; Yamamoto O; Toda S; Narisawa Y
J Dermatol; 2008 Jul; 35(7):419-25. PubMed ID: 18705829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
